Miami, Florida (PRWEB) May 21, 2013
AAG Health, the leading age management and hormone optimization center located in Miami, announced today that it has acquired the OligoScan test made by leading European medical device manufacturer, Physioquanta Group.
Using advanced spectrophotometry technology, the OligoScan device is capable of measuring in real time the bioavailability of up to 14 heavy metals, 20 trace elements (minerals), and oxidative stress levels.
Early detection of high toxic metal substances such as mercury, lead, aluminum, and arsenic, will make it possible to identify and treat any issues associated with heavy metal poisoning. Small amounts of some of these metals are common in our environment and food, but large amounts of any of them may cause acute or chronic toxicity (poisoning).
Heavy metal toxicity can result in damaged or reduced mental and central nervous function, lower energy levels, and damage to blood composition, lungs, kidneys, liver, and other vital organs. The OligoScan finds what toxic metals are in the body so one can take corrective measures.
“This non-evasive test provides AAG Health clients a unique insight as to what’s hiding in their body tissue. The negative impact of heavy metals in humans is demonstrated by numerous studies published by leading research institutes such as the World Health Organization, FDA, Mayo Clinic and other entities,” said AAG Health’s CEO, Mark White.
“Our clients are unquestionably the big winner of the OligoScan test. Test results are realized in real time with the ability of immediate interpretation. This test, along with others on offer at our practice, ensures that all AAG Health clients have access to important clinical information, making sure their treatment plans are safe and effective," continued Mr. White.
In addition to heavy metal toxicity detection, the OligoScan also analyzes the body’s mineral imb
Copyright©2012 Vocus, Inc.
All rights reserved